News Daily News A Closer Look at Bleeding Avoidance Strategies in PCI Reveals Little Impact on Outcomes Yael L. Maxwell April 25, 2016
News Daily News Label Update for Bivalirudin Warns of Acute Stent Thrombosis With PCI for STEMI, Recommends Continued Infusion Shelley Wood April 18, 2016
News Conference News ACC 2016 Comparing the Novel Oral Anticoagulants: Effectiveness Similar, but Apixaban May Come With Less Bleeding Todd Neale April 06, 2016
News Conference News ACC 2016 Meta-analysis Delves Into Bivalirudin Versus Heparin Debate in Primary PCI Yael L. Maxwell April 04, 2016
News Daily News New Roles for Anticoagulation Clinics in an Era of Non-Warfarin Options Todd Neale March 01, 2016
News Daily News In the Real World, Dabigatran and Warfarin Give Equal Stroke Protection to A-fib Patients Todd Neale January 25, 2016
News Daily News Cath-Lab Complications: New Analysis Pinpoints Rate and Risks of Intraprocedural Thrombotic Events in ACS Shelley Wood January 21, 2016
News Daily News Former FDA Staffer Says Missing Data Across Antithrombotic Trials Cast Doubt on Drug Effects Shelley Wood January 18, 2016
News Daily News Early Data Show Promise for Reversible, Fast-Acting, Antiplatelet Drug PZ-128 Caitlin E. Cox December 20, 2015
News Daily News Study Affirms Cost-Effectiveness of Watchman LAA Closure Device for Stroke Reduction L.A. McKeown December 14, 2015
News Daily News Case Study Highlights Risks for A-fib Patients Undergoing PCI in Absence of Evidence-Based Guidelines Yael L. Maxwell December 14, 2015
News Daily News Bivalirudin’s Bleeding Benefits Dampened by PCI Advances, Analysis Shows Todd Neale December 14, 2015
News Conference News AHA 2015 Reversal Agents Safely Stop Effects of Novel Oral Anticoagulants Yael L. Maxwell November 10, 2015
News Industry News FDA approves Praxbind, the first reversal agent for the anticoagulant Pradaxa October 20, 2015
News Industry News Similar Results With Bivalirudin Compared With Heparin Anticoagulation In TAVR Patients October 15, 2015
News Conference News TCT 2015 BRAVO 3: Bivalirudin Similar to Heparin in Transfemoral TAVR Yael L. Maxwell October 15, 2015
News Daily News Upstream Bivalirudin Best in NSTE-ACS Patients With Planned Invasive Strategy L.A. McKeown September 21, 2015
News Conference News ESC 2015 MATRIX Antithrombin: Bivalirudin Fails to Reduce Net Adverse Events vs Heparin in ACS Patients Undergoing PCI Yael L. Maxwell September 02, 2015
News Conference News ESC 2015 NSAIDs Plus Anticoagulants a Bad Combination Caitlin E. Cox September 01, 2015